For patients who suffer from an arthritic condition, the symptoms are often difficult to manage. Leading to impaired quality of life, often associated with pain and stiffness of the joints, patients with rheumatoid arthritis are on a never ending quest to find resolution of symptoms associated with this arthritic disorder.
Rheumatoid arthritis, for some individuals, is the result of a complication in which there is an overproduction of tumor necrosis factor alpha. With the overproduction, there is a risk for abnormal immune response that leads to the development of complications such as rheumatoid arthritis. With chronic synovitis and joint destruction, individuals who suffer from this complication often lead an impaired quality of life attributed to pain, decreased range of motion and impaired mobility.
To improve health outcomes in patients with overproduction of tumor necrosis factor alpha, the use of a blocking therapy is usually recommended. Therefore, in rheumatoid arthritis patients, who suffer from this overproduction, the use of blocking therapy involving the administration of Infliximab is quite common. However, even with this form of prescription drug blocking therapy, patients who use Infliximab, to control rheumatoid complications, may be at-risk for other types of infections.
Pneumonia is a common health risk for patients who use Infliximab to manage overproduction of tumor necrosis factor alpha. Creating an increase in inflammatory reactions within the lungs, if you suffer from rheumatoid arthritis, it is important to manage this health complication carefully and accurately. In many cases, as a rheumatoid arthritis patient, the use of Infliximab is initiated without much education in the potential adverse secondary health risks.
If, while using Infliximab, you find that you experience a decrease in respiration, or you suffer from upper respiratory infection, it is important to seek medical attention as soon as possible. Because, as a rheumatoid arthritis patient, you may be at a greater risk for inflammatory complications, these symptoms may be indicative of the early development of pneumonia. In many cases, the complications can be effectively treated with early diagnosis and treatment.
As with any complication arising out of treatment for rheumatoid arthritis, it is important to know what your risk factors are and how those risks may play a role into your overall health. While Infliximab is a great treatment for the development and management of rheumatoid arthritis, it can pose respiratory complications in some patients. Understanding these risks will provide for a greater health outcome in the management of your rheumatoid complication.